FDA-approved for advanced HCC treatment Inhibits RAF/MEK/ERK and VEGF receptor tyrosine kinases Suppresses PIN1-mediated Mcl-1 protein stabilization Reduces PIN1 expression by Inhibiting Rb phosphorylation Enhances apoptosis and inhibits cell proliferation. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.